Prognostic value of the presence and expression of TLR7 in non small cell lung carcinoma (NSCLC) patients

被引：0
|
作者：
Chatterjee, S. [1 ]
Crozet, L. [1 ]
Damotte, D. [1 ]
Alifano, M. [2 ]
Dieu-Nosjean, M. C. [1 ]
Fridman, W. H. [1 ]
Sautes-Fridman, C. [1 ]
Cremer, I. [1 ]
机构：
[1] Cordeliers Res Ctr, Immune Microenvironm & Tumor Team 13, UMRS872, Paris, France
[2] Hosp Hotel Dieu, AP HP, Serv Anat Pathol & Chirurg Thorac, Paris, France
来源：
IMMUNOLOGY | 2012年 / 137卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：301 / 301
页数：1
相关论文
共 50 条
  • [21] Usefulness of MicroRNAs as Prognostic Factors in Early Stage Non Small Cell Lung Carcinoma (NSCLC)
    Ramirez, J.
    Campayo, M.
    Cabanas, M. L.
    Vinolas, N.
    Marrades, R.
    Molins, L.
    Monzo, M.
    LABORATORY INVESTIGATION, 2012, 92 : 486A - 487A
  • [22] Usefulness of MicroRNAs as Prognostic Factors in Early Stage Non Small Cell Lung Carcinoma (NSCLC)
    Ramirez, J.
    Campayo, M.
    Cabanas, M. L.
    Vinolas, N.
    Marrades, R.
    Molins, L.
    Monzo, M.
    MODERN PATHOLOGY, 2012, 25 : 486A - 487A
  • [23] Expression of Sox2 in non-small cell lung carcinoma (NSCLC)
    Khoor, A.
    Stahlman, M.
    Kreinest, P.
    Whitsett, J.
    HISTOPATHOLOGY, 2012, 61 : 206 - 206
  • [24] Prognostic Value of HLA-A2 Status in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
    Mezquita, Laura
    Charrier, Melinda
    Faivre, Laura
    Remon, Jordi
    Planchard, David
    Bluthgen, Maria
    Dupraz, Louise
    Facchinetti, Francesco
    Lahmar, Jihene
    Gazzah, Annas
    Soria, Jean -Charles
    Pignon, Jean Pierre
    Chaput, Nathalie
    Besse, Benjamin
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S965 - S966
  • [25] Prognostic and predictive value of vascular endothelial growth factor (VEGF) in patients with non small cell lung cancer (NSCLC)
    Gregorc, V
    Ludovini, V
    Pistola, L
    Ceresoli, GL
    Tofanetti, F
    Ferraldeschi, M
    Schipani, S
    Darwish, S
    Floriani, I
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S77 - S78
  • [26] Prognostic value of epidermal growth factor receptor expression in operable non-small cell lung carcinoma
    Seyhan, Ekrem Cengiz
    Altin, Sedat
    Cetinkaya, Erdogan
    Sokucu, Sinem
    Abali, Hulya
    Buyukpinarbasili, Nur
    Fener, Neslihan
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2010, 5 (05): : 305 - 311
  • [27] Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer
    Peng, Wen-Jia
    Zhang, Jun-Qing
    Wang, Bing-Xiang
    Pan, Hai-Feng
    Lu, Man-Man
    Wang, Jing
    CLINICA CHIMICA ACTA, 2012, 413 (13-14) : 1121 - 1126
  • [28] Clinical and prognostic value of hTERT mRNA expression in patients with non-small-cell lung cancer
    Zalewska-Ziob, Marzena
    Dobija-Kubica, Katarzyna
    Biernacki, Krzysztof
    Adamek, Brygida
    Kasperczyk, Janusz
    Brulinski, Krzysztof
    Ostrowska, Zofia
    ACTA BIOCHIMICA POLONICA, 2017, 64 (04) : 641 - 646
  • [29] Prognostic value of HMGB3 expression in patients with non-small cell lung cancer
    Song, Ning
    Liu, Bao
    Wu, Jian-Ling
    Zhang, Rui-Fang
    Duan, Lin
    He, Wen-Shu
    Zhang, Cong-Min
    TUMOR BIOLOGY, 2013, 34 (05) : 2599 - 2603
  • [30] CEA response as a prognostic marker in non-small-cell lung carcinoma (NSCLC) patients treated with gefitinib or erlotinib
    Ceballos, J.
    Lopez-Picazo, J.
    Reyna, C.
    Moreno Jimenez, M.
    Perez-Gracia, J. L.
    Ponz Sarvise, M.
    Olier, C.
    Gil Bazo, I.
    Gurpide, A.
    Garcia-Foncillas, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345